Children with juvenile idiopathic arthritis already face increased risk of bacterial infections, but use of high-dose steroids could significantly increase that risk, according to research from the University of Alabama-Birmingham. Read the full report in Becker’s Hospital Review on juvenile…
Uncategorized
The Institute for Minimally Invasive Surgery in Dallas, which is a Meridian Surgical Partners facility, is the first surgery center to purchase the O-Arm Surgical Imaging System, which provides intraoperative CT navigation, to improve surgical precision and reduce the need…
The Better Pharmaceuticals and Devices for Children Act, introduced by Senator Jack Reed (D-R.I.), has been passed by the Senate Health, Education, Labor and Pensions Committee. Read the full report in Becker’s Hospital Review on the Better Pharmaceuticals and Devices…
The CDC has released a statement that reiterates its position on the use of single dose and single use vials in an effort to ensure clinicians are clear about CDC guidelines. Read the full report in Becker’s Hospital Review on…
Here are 15 new statistics on ASC administrator salary, based on data from VMG Health's Multi-Specialty ASC Intellimarker 2011.
Advertisement
Kensey Nash Corp. has announced it will be acquired by Netherlands-based Royal DSM, according to a news release.
In March, St. Luke's Episcopal Hospital in Houston became one of ten hospitals awarded accreditation as a Mission: Lifeline Heart Attack Referring/Receiving Center by the American Heart Association and the Society of Chest Pain Centers. These two organizations partnered to…
The SURPASS checklist, developed by researchers in the Netherlands to reduce complication and mortality rates, has made this tool available for use.
A study reveals that the pain medication Vioxx suppressed the production of enzymes that play a key role protecting the heart, according to a Wall Street Journal report.
Drug developer Zalicus is advancing its neuropathic pain drug candidate, Z160, into multiple Phase 2 clinical trials, according to a Mass High Tech report. Z160 is an oral, N-type calcium channel blocker for neuropathic pain.